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ABSTRACT
Objective: The Zwolle Outpatient Diabetes project
Integrating Available Care (ZODIAC) study was initiated
in 1998 to investigate the effects of shared care for
patients with type 2 diabetes mellitus (T2DM) in the
Netherlands, and to reduce the number of diabetes-
related complications. Benchmarking the performance
of diabetes care was and is an important aspect of this
study. We aimed to investigate trends in diabetes care,
within the ZODIAC study for a wide variety of quality
indicators during a long follow-up period (1998–2008),
with special interest for different age groups.
Design: Prospective observational cohort study.
Setting: Primary care, Zwolle, The Netherlands.
Participants: Patients with T2DM.
Methods: A dataset of quality measures was collected
annually during the patient’s visit to the practice nurse
or general practitioner. Linear time trends from 1998 to
2008 were estimated using linear mixed models in
which we adjusted for age and gender. Age was
included in the model as a categorical variable: for each
follow-up year all participants were categorised into the
categories <60, 60–75 and >75 years. Differences in
trends between the age categories were investigated by
adding an interaction term to the model.
Results: The number of patients who were reported to
participate increased in the period 1998–2008 from
1622 to 27 438. All quality indicators improved in this
study, except for body mass index. The prevalence
albuminuria decreased in an 11-year-period from 42%
to 21%. No relevant differences between the trends for
the three age categories were observed. During all years
of follow-up, mean blood pressure and body mass
index were the lowest and highest, respectively, in the
group of patients <60 years (data not shown).
Conclusions: Quality of diabetes care within the Dutch
ZODIAC study, a shared care project, has considerably
improved in the period 1998–2008. There were no relevant
differences between trends across various age categories.
INTRODUCTION
Ever since it was established that type 2 dia-
betes mellitus (T2DM) leads to signiﬁcant
morbidity and mortality,1 2 prevention and
(early) treatment of both microvascular and
macrovascular complications of T2DM have
become important goals in diabetes care.
Efforts to improve the quality of diabetes care
are necessary in order to reduce morbidity
and mortality associated with T2DM.3 4 Since
adequate treatment of patients with T2DM
often needs the involvement of more than
one caregiver, shared care, deﬁned as care
ARTICLE SUMMARY
Article focus
▪ Shared care, defined as care for patients with a
chronic condition provided in cooperation
between primary and secondary healthcare, has
been promoted and developed in order to reduce
the number of diabetes-related complications.
▪ There are limited data whether improvements in
diabetes care in the past few decades are com-
parable across different age categories.
▪ We aimed to investigate trends in diabetes care,
within a shared care project, during a long
follow-up period (1998–2008), with a special
focus on different age groups.
Key messages
▪ Quality of diabetes care within the Dutch ZODIAC
study, a shared care project, has considerably
improved in the period 1998–2008.
▪ Large improvements were observed for all
quality indicators studied in this study, except
for body mass index.
▪ No relevant differences between the trends for
different age categories were observed.
Strengths and limitations of this study
▪ Strengths of our study are the long follow-up
period and the high number of participants.
▪ A causal relationship between shared care and
the observed improvements cannot be proved
due to the observational design of our study.
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for patients with a chronic condition provided in
co-operation between primary and secondary healthcare,
has been promoted and developed.5
The Zwolle Outpatient Diabetes project Integrating
Available Care (ZODIAC) study was initiated in 1998 to
investigate the effects of shared care for patients with
T2DM in the Netherlands.6 Benchmarking the perform-
ance of diabetes care was and is an important aspect of
this initiative. Previous reports from the ZODIAC study
showed that structured shared care with task delegation
to nurses leads to improvements in quality of diabetes
care and life expectancy.6–8 However, effectiveness of
shared care in general was not demonstrated in a 2007
Cochrane review.5 Inadequate length of follow-up was
mentioned by the authors as a possible explanation for
the lack of evidence.
Although diabetes care has improved considerably
during the past few decades in patients with diabetes,
there are limited data regarding whether these improve-
ments are comparable across different age categories.9 10
A cross-sectional study from France showed that quality of
care had considerably improved for patients ≥65 years
with T2DM in the period 2001–2007.11 Unfortunately,
trends for patients >75 years were not described separ-
ately in this study. Although the number of patients with
T2DM >75 years is increasing, the evidence for cardiovas-
cular risk interventions in this age category is low.12 Data
from observational studies show that classic cardiovascu-
lar risk factors may even have different consequences in
elderly patients.13–17
In the present study, we aimed to investigate trends in
diabetes care, within a shared care project, for a wide
variety of quality indicators during a long follow-up
period (1998–2008). Because of limited evidence for car-
diovascular risk interventions in old age, we had speciﬁc
interest whether the same trends were observed for dif-
ferent age groups (<60, 60–75 and >75 years).
METHODS AND PATIENTS
Study population and ZODIAC
The ZODIAC study started in 1998 as a prospective obser-
vational study for patients with T2DM.6 Participating
practices were allocated to one of the two intervention
groups or to the standard care group. The interventions
involved extensive or limited task delegation from
general practitioners to practice nurses and/or diabetes
specialist nurses. Moreover, it included a diabetes register,
structured recall, facilitated generalist–specialist commu-
nication, audit and feedback, patient-speciﬁc reminders
and it emphasised patients’ education.6 The patients par-
ticipating in the ZODIAC study are known with T2DM
and exclusively treated in primary care. Patients who were
already treated in secondary care for their diabetes,
patients with a very short life expectancy (including
patients with active cancer) and patients with insufﬁcient
cognitive abilities were excluded from participation. In
the ﬁrst few years of ZODIAC, only patients in the
surrounding area of the city of Zwolle participated in the
study. Because of the improvements in the quality of dia-
betes care in the two intervention groups, the shared
care project has expanded gradually in the past decade.
First, the shared care project became the standard for
diabetes care in the entire Zwolle region (2002–2003),
and in 2005–2006 the project expanded to the northeast
region of the Netherlands. Patients who were received
standard care in the beginning of the project, switched to
shared care in 2002–2003 when the shared care project
became the standard for the entire Zwolle region. These
patients were included in the current analyses from the
moment they switched to shared care. The number of
participating general practitioners (GPs) has increased
from 53 in 1998 to 459 in 2008. Patient numbers
increased from 1622 to 27 438 in this time frame, and
nowadays even more than 60 000 patients are participat-
ing. A benchmark of annually gathered quality measures
of this cohort, based on the guidelines of the Dutch
College of General Practitioners and the Dutch Diabetes
Federation, has been developed.18
Data collection
The dataset of quality measures is collected annually
during the patient’s visit to the practice nurse and/or
GP. These quality measures are collected in the GPs’
patient information systems and each year the relevant
data are uploaded and sent to our diabetes centre for
benchmarking and research purposes. At baseline, add-
itional data were collected including a full medical
history. The dataset contains many quality measures,
including data on cardiovascular risk control, treatment
and complications. Distinction is made between process
and outcome measures. Process measures indicate
whether tests or assessments have been performed, for
example, the number of patients whose HbA1c level has
been determined. Outcome measures reﬂect the results
of the assessments, such as the mean systolic blood pres-
sure or the proportion of patients with a systolic blood
pressure <140 mm Hg. Table 1 shows an overview of the
measures we investigated in this study for each year of
follow-up.
Participating practices were instructed to perform
blood pressure measurements in supine position after at
least 5 min of rest, and to calculate the mean blood pres-
sure of two recording for each visit. Laboratory data
(HbA1c, serum creatinine and lipid proﬁle) were deter-
mined using standard hospital procedures. Until 2005,
all procedures were performed in the clinical chemistry
laboratory of the Isala Clinics (Zwolle region). Because
of the expansion of the project in 2005–2006 to the
northeast region of the Netherlands, laboratories of
other regions started participating. HbA1c was measured
using afﬁnity chromatography high-performance liquid chro-
matography (Ultra 2, Trinity Biotech, Kansas City,
Missouri, USA) in the Zwolle region (coefﬁcient of vari-
ation approximately 1.5%).19 There are differences in
the methods used in the various laboratories in the
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northeast region of the Netherlands. Generally speaking,
the variation coefﬁcient has decreased in the study
period due to the worldwide standardisation of HbA1c
measurements and improved techniques. Because of the
high number of patients in the last years of the project,
it is not likely that differences in the coefﬁcient of vari-
ation coefﬁcient have inﬂuenced the results.
Statistical analyses
Continuous variables are represented as means and 95%
CI for the normally distributed values. Normality was
evaluated using Q–Q plots and histograms. Nominal
variables are represented as the proportion of patients
together with 95% CIs. The database contained 37 320
unique patients and data of 92 340 unique yearly dia-
betic check-ups. For 9279 patients, we only had data of
one diabetic check-up. The descriptive statistics were
strictly cross-sectional and included observations of all
visits (n=92 340). Since cross-sectional outcomes are
inﬂuenced by changes in population (inmigration and
outmigration), besides changes in quality of care, cross-
sectional outcomes tend to overestimate time trends
when compared to longitudinal analyses.20 Therefore,
we estimated linear time trends from 1998 to 2008 using
a linear mixed model for continuous variables (SAS
PROC MIXED) and a generalised linear mixed model
for binary variables (PROC GLIMMIX, using the
logit link function) in which we adjusted for age and
gender. In all analyses, time, age and sex were modelled
as ﬁxed effects. Since the estimated linear time trends
are based on individual changes over time, data of
at least two visits were necessary. As a consequence,
these longitudinal analyses were based on 83 061 visits of
28 041 patients. Age was included in the model as a cat-
egorical variable: for each follow-up year all participants
were categorised into the categories <60, 60–75 and
>75 years. All time trends were visually inspected and a
quadratic time trend was only introduced when such a
trend was likely based on the plot. Differences in trends
between men and women and the age categories were
investigated by adding interaction terms for age and
time and sex and time to the model. A signiﬁcant inter-
action for age and time means that differences exist
between the time trends for the three age categories.
The same applies for the interaction between sex and
time. All analyses were performed with SPSS V.18.0.0
software (SPSS Inc, Chicago, Illinois, USA) and with SAS
V.9.2 software (SAS Institute Inc, Cary, North Carilina,
USA).
The manuscript was written based on the
‘Strengthening the reporting of observational studies in
epidemiology’ statement.21
Ethics statement
The ZODIAC study and the informed consent proced-
ure were approved by the local medical ethics commit-
tee of the Isala Clinics, Zwolle, the Netherlands. In the
ﬁrst years of ZODIAC, verbal informed consent was
obtained from all patients and the consent was docu-
mented in the patient’s records. According to Dutch law,
written informed consent was not necessary for this type
of study in 1998. Nowadays, written informed consent is
obtained. All data were analysed anonymously.
Table 1 Overview of the process and outcome measures studied
Parameter Process measure Outcome measure





NA Percentage diet only
Percentage oral medication only
Percentage insulin with or without oral
medication
Blood pressure Percentage of patients measured Mean SBP (mm Hg)
Percentage SBP<140 mm Hg
Antihypertensive
treatment
NA Percentage patients using antihypertensive
drugs
Cholesterol–HDL ratio Percentage of patients measured Mean total cholesterol–HDL ratio
Percentage total cholesterol–HDL ratio<4
Lipid-lowering drugs NA Percentage patients using lipid-lowering drugs
Renal function Percentage of patients with creatinine
measurements
Mean creatinine (μmol/l)
Percentage of patients with ACR measurements Percentage microalbuminuria
Percentage macroalbuminuria
BMI Percentage of patients measured Mean BMI (kg/m2)
Percentage BMI<25 kg/m2
Abbreviations: ACR, albumin–creatinine ratio; BMI, body mass index; HDL, high-density lipoprotein; NA, not applicable; SBP, systolic blood
pressure.
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RESULTS
The number of patients who were reported to participate
in this shared care project increased in the period 1998–
2008 from 1622 to 27 438. Mean age decreased with time
from 68.9 to 67.4 years (p for trend <0.0001). A gradual
increase was observed for the proportion of male patients
participating in the project. Median diabetes duration
remained rather constant at 5 years throughout the study
period. The proportion of patients aged older than
75 years was 31% in 1998 and declined to 26.3% in 2008.
The number of patients who did not participate in the
study due to short life expectancy of insufﬁcient cognitive
abilities is unknown after 1999. The results for all process
and outcome measures of each year for the overall study
group are presented in table 2.
Process measures
All process measures show a similar trend (table 2): a
gradual increase in the ﬁrst years of the project followed
by a decrease in the years 2002 and 2003, an increase in
the upcoming 2 years, followed by a decrease in 2006
again and a rising trend in the process measures in the
last 2 years. Body mass index (BMI), the lipid proﬁle
and the albumin–-creatinine ratio (ACR) were less often
measured in patients aged >75 years compared to the
younger patients (p for interaction with age for all vari-
ables <0.0001). Figure 1 illustrates the trends for the
process measure of ACR, BMI and blood pressure in the
total study population.
Outcome measures
Figure 2 presents the trends for outcome measures over
time for the overall study group and also stratiﬁed
according to the three age categories.
Glycemic control and diabetes treatment
The decline in mean HbA1c over time is reﬂected in the
proportion of patients achieving the target value of <7%;
35.8% in 1998 compared to 67% in 2008. The differences
between the three age categories seem to be small,
although the proportion of patients with an HbA1c≥8.5%
tended to be the highest for patients aged <60 years in all
years (p for interaction with age 0.0773). The proportion
of patients treated with only a diet increased over time
from 16.6% to 23.8%. A total of 15.5% used insulin in 1998
and this proportion declined to 12.8% in 2008.
Blood pressure and treatment
Mean blood pressure has decreased over time in all age
groups, with the lowest values in the youngest patient
category (p for interaction with age <0.0001). In 1998
about one-ﬁfth (22%) had a systolic blood pressure
<140 mm Hg, compared to 47.7% in 2008. The number
of patients with antihypertensive medication increased
in all age groups. With advancing age, the number of
patients using these agents also increased (p for inter-
action with age <0.0001). A remarkable decrease in 2003
was directly followed by a large increase in 2004.
Lipids and treatment
Mean total cholesterol–high-density lipoprotein (HDL)
ratio has decreased in the period 1998–2006, followed by
a small increase in the last 2 years (p for quadratic trend
<0.0001). Patients aged <60 years performed worse with
regard to the mean cholesterol-HDL ratio compared to
the older patients categories (p for interaction with age
<0.0001). Approximately one-quarter (23%) of the
patients participating in 1998 had a ratio <4. This propor-
tion increased to 61.1% in 2008, which is also reﬂected in
the number of patients receiving lipid-lowering drugs:
10.2% in 1998 and 62.8% in 2008. As was the case with
the number of patients using antihypertensives, a remark-
able decrease was also observed for the number of
patients using lipid-lowering drugs in 2003.
Renal function
Mean values of serum creatinine have remained rather
constant throughout the study period. The prevalence of
microalbuminuria and macroalbuminuria in 1998 was
33.6% and 8.3%, respectively. These proportions
declined over time to 18.5% and 2.4%, respectively. The
highest prevalence of microalbuminuria was observed for
the group >75 years (p for interaction with age <0.0001).
Body mass index
After an increase in the ﬁrst 5 years, mean BMI
remained rather constant afterwards. In the highest age
category, the highest proportion of patients with a
BMI<25 kg/m2 was observed and vice versa (p for inter-
action with age <0.0001).
DISCUSSION
Quality of diabetes care within the Dutch ZODIAC study,
a shared care project, has considerably improved in the
period 1998–2008. Large improvements were observed
for all quality indicators studied in this study, except for
BMI. Each time that large groups of general practices
joined the shared care initiative (2002 and 2006), there
was a short relapse in the process measures, which was
mostly redressed within 1 year. No relevant differences
between the trends for the three age categories were
observed. During all years of follow-up, mean blood
pressure and BMI were the lowest and highest, respect-
ively, in the group of patients <60 years. Patients in this
age category also had the highest cholesterol–HDL ratio
values and the lowest albumin–ACR values throughout
the study period.
Striking changes were the increase in the use of blood
pressure and lipid-lowering drugs. This increased use
was also reﬂected in the improvements in blood pressure
and lipid levels. Remarkably, the decrease in HbA1c was
not accompanied by an increase in the proportional use
of oral blood glucose-lowering drugs or insulin. Instead,
an increase in the proportion of patients on a diet was
observed for all age categories. One could hypothesise
that more patients with early diagnosed T2DM were
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Table 2 Characteristics of all participants in the Zwolle Outpatient Diabetes project Integrating Available Care study for the period 1998–2008
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
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All data are mean values or proportions together with their 95% CIs, or median values together with the interquartile range.
*p For trend is based on age- and gender-adjusted analyses.




















































included in the last few years of the study. However,
median diabetes duration did not relevantly change
throughout the study. Patient education and better
adherence to lifestyle advices could be other possible
explanations.
The results of our study conﬁrm previous reports that
also observed improvements in risk factor control during
the past few decades.9–11 22 However, this is the ﬁrst
study presenting the results of a large shared care
project with a follow-up period of more than 10 years.
Although this study demonstrates the impressive results
that have been achieved in a shared care setting, it
should be emphasised that causality cannot be proved
by our study. The two decreases in the process measures,
which were observed after the expansion of the ZODIAC
project in 2002 and 2006, and the quick rebound after-
wards, suggest positive effects of participating in the
project (ﬁgure 1). However, there are many other
factors that may also explain the improvements in
quality of care. First, national and international guide-
lines advocating stricter treatment in patients with
T2DM have been published in the period 1998–2008.
For example, in 1999 and in 2006 revisions of the guide-
line T2DM of the Royal Dutch College of General
Practitioners were published.18 23 It could be that adher-
ence to these guidelines, irrespective of participating in
shared care projects, is the most important factor
explaining the general tendency to improved diabetes
care. Second, ﬁnancial incentives from health insurance
companies for general practitioners that provide care of
a high quality have been introduced in the past decade.
Although a recent Cochrane review concluded that
there is insufﬁcient evidence to support the use of such
ﬁnancial incentives, positive effects on quality of care
can also not be excluded.24
Figure 2 Outcome measures for the total study population
and stratified according to age (<60 (black line), 60–75
(grey line) and >75 (black dashed line) years).
Figure 1 Process measures for albumin-creatinine ratio
(ACR), body mass index (BMI) and blood pressure.
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To our knowledge, our study is the ﬁrst study that also
speciﬁcally investigated the trends in diabetes care for
patients aged older than 75 years. This population is of
special interest for two reasons. First, more than one-
quarter of the type 2 diabetic population in primary
care in the Netherlands is >75 years. Second, clinical
trials in old age investigating cardiovascular risk inter-
ventions, such as hypertension treatment, are either
lacking or subject to selection bias.25–27 Since the evi-
dence for strict cardiovascular risk control in old age is
low, old age is characterised by a high prevalence of
complications and comorbidities, and elderly patients
are at increased risk for possible adverse events, less
strict treatment targets for elderly patients with T2DM
have been advocated in the literature.28–30 Generally
speaking, individualising target values is being increas-
ingly advocated in the literature nowadays.30 Take for
example, hypertension treatment in old age. Whereas a
systolic blood pressure target value of 140 mm Hg
should be used for patients >75 years without many
comorbidities who are not using insulin, it is unknown
as to whether this target value is also appropriate for the
overall elderly population.27 In conclusion, although the
current study observed the same improvements in the
various quality measures across all age categories, it
remains uncertain as to whether these improvements
will have the same beneﬁcial effects on cardiovascular
comorbidity and mortality in the oldest elderly as in
younger patients with T2DM.
Our study has several important limitations that need
to be addressed. First, it is important to realise that the
cross-sectional data presented in table 2 and ﬁgure 2 are
inﬂuenced by changes in population (inmigration and
outmigration), besides possible changes in quality of
care. Since the estimated linear time trends were based
on individual changes over time, it is possible to con-
clude that there is an improvement over time. However,
these improvements are probably smaller than the cross-
sectional data suggest, since cross-sectional outcomes on
HbA1c overestimate improvements over time when com-
pared with longitudinal outcomes.20 Second, because of
its observational design a causal relationship between
shared care and the observed improvements cannot be
proven. Unfortunately, we were not able to include a
control group of patients with diabetes receiving stand-
ard care. Third, the data in our study have been pro-
vided by practice nurses and GPs as part of the yearly
benchmark. As a consequence, the quality and reliability
of the data are dependent on the accuracy of the data
providers. For example, the number of patients using
lipid-lowering treatment in 2003 is an extreme outlier
compared to the other years and is probably not repre-
sentative for the actual number of patients. This differ-
ence suggests a fault in providing or collecting the data.
When a patient is registered as not using a statin, this
could either mean that he or she is actually not using a
statin or that it is incorrectly registered. However, with
respect to the process parameters this may have led at
the most to an underestimation of the actual measures.
Also, our study only comprises patients whom data have
been reported by the GPs. It is not unlikely that GPs
have opted not to provide data of patients who never
show up at their diabetes check-ups. Furthermore, the
number of patients who did not participate in the study
due to short life expectancy of insufﬁcient cognitive abil-
ities is unknown after 1999.
Strengths of our study are the long follow-up period
and the high number of participants, especially in the
last years of the ZODIAC study. Because of the size of
our database, it is important to realise that small differ-
ences may easily lead to statistical signiﬁcant differences
while some can hardly be called relevant. For example,
the mean serum creatinine level ﬂuctuates around
95 μmol/l throughout the whole study period, but there
is a slight positive (ie, upward) linear trend for males
above 75 years, while for women there is a slight nega-
tive linear trend for all age categories while the overall
linear (very slightly positive) trend is nevertheless highly
signiﬁcant (p<0.0001).
In conclusion, our study shows that quality of diabetes
care within the Dutch ZODIAC study has improved in
the period 1998–2008, irrespective of age. Future studies
are needed to elucidate whether there is a causal rela-
tionship between shared care and the improvements.
Whether the large improvements observed in old age
will lead to reductions in morbidity and mortality also
remains to be determined.
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